Hypercholesterolemia Clinical Trials

A listing of Hypercholesterolemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 159 clinical trials
Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

To Evaluate the Efficacy and Safety of Combination Therapy of AGT and AGZ Versus Monotherapy of AGT in Patients With Primary Hypercholesterolemia.

  • 0 views
  • 23 Mar, 2022
  • 1 location
A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A

The purpose of this study is to evaluate the efficacy and safety of AD-221 and AD-221A

  • 0 views
  • 24 Mar, 2022
  • 1 location
Unravelling the Impact of Diet on Cardiovascular Health in Heterozygous Familial Hypercholesterolemia. (FH-Diet)

The investigators will first conduct a fully controlled dietary randomized crossover trial (RCT) including 72 adults with HeFH to investigate the impact of a diet low in red and processed meats and high in plant foods, reflecting Canada's Food Guide, in place of a standard North-American diet on LDL-cholesterol (LDL-C) …

Accepts healthy volunteers
cholesterol measurement
cholesterol level
cardiovascular disease
hypercholesterolemia
  • 0 views
  • 23 Mar, 2022
  • 1 location
Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia (ACCURATE)

ACCURATE will test the hypothesis that opportunistic genetic testing for Familial Hypercholesterolemia (FH) in patients admitted to hospital with an acute coronary syndrome will increase the

lipid-lowering therapy
LDL Cholesterol
genetic analysis
cholesterol level
acute coronary syndrome
  • 0 views
  • 23 Mar, 2022
  • 1 location
Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia

evaluate the tolerability and safety of multiple-dose repeated administration of IBI306 in the Chinese population with hypercholesterolemia, and to recommend the dose for the second phase. The main purpose

  • 0 views
  • 10 Jul, 2021
  • 1 location
Clinical Trials of Five Different Food Supplements With Restriction Diet in Adults (FOODSU)

In recent years, dietary supplement are of great interest for the improvement of human health. This study is designed as a parallel, randomized, double blind study exploring the efficacy of two months daily oral dosing of five different food supplements together with diet restriction in 120 otherwise healthy overweight or …

Accepts healthy volunteers
  • 0 views
  • 15 May, 2022
  • 1 location
Statins in Reducing Events in the Elderly (STAREE) Heart Sub-study

The STAREE-HEART sub-study will examine the effect of statin treatment over a 3-year period compared with placebo on markers of cardiac ageing. This will include determining global longitudinal strain with transthoracic echocardiography, atrial fibrillation with home measures twice daily for two weeks and changes in biomarkers.

electrocardiogram
fibrillation
hmg-coa reductase inhibitors
12 lead ECG
heart study
  • 10 views
  • 26 Jan, 2021
  • 1 location
Left Ventricular Hypertrophy Reduction With Statins in Hypertensive Patients

Experimental studies have showed that statins reduce left ventricular hypertrophy. The main objective is to observe the reduction of left ventricular hypertrophy with statins in hypertensive patients. The hypothesis is that patients treated with statins will have a reduction of at least 10% compared with patients treated only with antihypertensive …

valsartan
left ventricular hypertrophy
  • 4 views
  • 07 Nov, 2020
  • 1 location
Genetic Testing and Motivational Counseling for FH

To date, there are highly effective lipid-lowering drugs, the combination of which makes it possible to achieve the target level of LDL-C in most patients with familial hypercholesterolemia (FH

lipid-lowering therapy
atorvastatin
pcsk9
statin
ezetimibe
  • 0 views
  • 01 Nov, 2021
  • 1 location
Lipid Management in Renal Transplant Recipients Using Evolocumab.

Cardiovascular disease is the leading cause of mortality after renal transplantation, accounting for more than 30% of deaths. Elevated lipid levels (hyperlipidemia) are a frequent finding following transplantation and the immunosuppressive medications play a central role in the development or worsening of hyperlipidemia. In the general population, the correlation between …

  • 0 views
  • 13 May, 2021
  • 1 location